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Synthesis, characterization and biocompatibility 
studies of zinc oxide (ZnO) nanorods for biomedical 
application 
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Nanoparticles are increasingly being recognized for their potential utility in biological applications 
including nanomedicine. Here, we have synthesized zinc oxide (ZnO) nanorods using zinc acetate 
and hexamethylenetetramine as precursors followed by characterizing using X-ray diffraction, 
fourier transform infrared spectroscopy, scanning electron microscopy and transmission electron 
microscopy. The growth of synthesized zinc oxide nanorods was found to be very close to its 
hexagonal nature, which is confirmed by X-ray diffraction. The nanorod was grown perpendicular 
to the long-axis and grew along the [001] direction, which is the nature of ZnO growth. The 
morphology of synthesized ZnO nanorods from the individual crystalline nucleus was confirmed by 
scanning and transmission electron microscopy. The length of the nanorod was estimated to be 
around 21 nm in diameter and 50 nm in length. Our toxicology studies showed that synthesized ZnO 
nanorods exposure on hela cells has no significant induction of oxidative stress or cell death even in 
higher concentration (10 μg/ml). The results suggest that ZnO nanorods might be a safer 
nanomaterial for biological applications. 
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Nanotechnology has extraordinary potential to change our lives 
by improving existing products and enabling new ones. It 
facilitates the development of new materials in the 1100 nm 
range, comparable to the size range of biological molecules and 
structures [1]. Nanomaterials are very attractive materials for the 
manipulation, sensing and detection of biological structures and 
systems [2].
 
The principal factors which make nanomaterials 
different from their bulk counterparts include an increase in their 
relative surface area and quantum effects, which affect their 
physical and chemical properties [2]. This is due to the large 
surface area-to-volume ratio of nanoparticles, which increases 
surface free energy to a point that is comparable to their lattice 
energy. For example, a particle of 30 nm size has 5% of its atoms 
on its surface compared to 50% of the atoms on the surface of a 3 
nm particle [3]. The altered properties of nanomaterials, and 
their size similarity to naturally occurring cell structures, will 
allow them to interact readily with bio molecules and potentially 
affect the cellular responses in a dynamic and selective manner. 
Materials that exploit these characteristics are becoming 
increasingly attractive for use in novel biomedical applications. 
Nano structured materials exhibit unique properties related 
to their size, and are used in an array of applications such as 
optoelectronics, nano/microelectronics, sensors, transducers, 
cosmetics as well as medical applications such as biosensors, 
tissue engineering and drug delivery vehicles [4-6]. Although 
our understanding of the human body at nanometer scale has 
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improved tremendously, advances in therapeutic options for 
treating severe diseases, such as cancer and autoimmunity have 
lagged by comparison. In this regard, nanomedicine, which is the 
most important application of nanotechnology to medical 
problems, can offer new approaches. 
Zinc oxide [ZnO] is a semiconductor material with various 
configurations, much richer than of any other known 
nanomaterial [7,8]. At nanoscale, it posses unique electronic and 
optoelectronic properties and finds application as biosensors, 
sunscreens, as well as in medical applications like dental filling 
materials and wound healing [9]. Because of the indiscriminate 
use of ZnO nanoparticles, it is important to look at their 
biocompatibility with biological system. A recent study on ZnO 
reports that it induces much greater cytotoxicity than non-metal 
nanoparticles on primary mouse embryo fibroblast cells [10], 
and induces apoptosis in neural stem cell [11]. Published reports 
have shown that ZnO inhibits the seed germination and root 
growth [12]; exhibit antibacterial properties towards Bacillus 
subtilis and to a lesser extent to Escherichia coli [13]. Inhalation 
of ZnO compromises pulmonary function in pigs and causes 
pulmonary impairment and metal fume fever in humans [14,15]. 
Literature evidences showed that ZnO nanoparticles are the most 
toxic nanoparticle with the lowest LD50 value among the 
engineered metal oxide nanoparticles [16]. On the other hand, it 
was also reported that zinc oxide was not found to be cytotoxic to 
cultured human dermal fibroblasts [17]. In recent years, there has 
been an escalation in the development of techniques for 
synthesis of nanorods and subsequent surface functionalization. 
ZnO nanorods exhibit characteristic electronic, optical, and 
catalytic properties significantly different from other nano 
metals. Keeping in view of the unique properties and the 
extensive use of ZnO in many fields and also contradictory 
results on ZnO toxicity from both in-vitro and in-vivo studies, 
we report here to synthesize and characterize the ZnO nanorods 
on hela cells for its biocompatibility/toxicity. 
Materials and methods  
Materials 
Zinc acetate anhydrous (Zn (O2CCH3)2) and 
hexamethylenetetramine (C6H12N4) were purchased from Alfa 
Aesar (MA, USA), dulbecco’s modified magle medium 
(DMEM), phosphate buffered saline (PBS), fetal bovine serum 
(FBS), and hank’s balanced salt solution (HBSS) were obtained 
from Atlanta Biologicals, Inc. (Atlanta, GA). RPMI-1640 
medium, glutathione (GSH), 3-(4,5-dimethylthiozol-2-yl)-2, 
5-diphenyl tetrazolium bromide (MTT), dimethylformamide 
(DMF), penicillin and streptomycin, and glutathione assay kit 
were obtained from Sigma Chemical Co. (St. Louis, MO). 
2,7-dichlorofluorescein diacetate (DCF-DA) was purchased 
from Molecular Probes (Invitrogen Corporation, Carlsbad, CA). 
Lipid peroxidation assay kit (705002) was purchased from 
Cayman Chemicals (Ann Arbor, MI). Superoxide dismutase kit 
was purchased from Trevigen, Inc. Gaithersburg, MD, USA (Cat 
# 7500-100-K). Coomassie plus protein assay reagent was 
purchased from Thermo fisher (cat # 1856210). 
ZnO Nanorod synthesis 
The typical method employed is as follows. Equal volume 
of 0.1 M aqueous zinc acetate anhydrous and 
hexamethylenetetramine were mixed in a beaker using 
ultrasonication for about 30 min. After the mixture was mixed 
well, it was heated at 80ºC in water bath for 75 min, during 
which white precipitates were deposited at the bottom. When 
hexamethylenetetramine was heated, it decomposes into 
aldehyde and ammonia [18] which produces OH− ions. Then 
Zn2+ combined with OH− to form Zn (OH)42− and decomposed 
into ZnO after heating, as the following formula illustrate: 
 
C6H12N4 + 6H2O  
  6CH2O + 4NH3 
 
NH3 + H2O  
  NH4+   + OH− 
 
Zn2+ + 4OH−  
  Zn(OH)42−  
  ZnO 
 
Then the reaction mixture was incubated for 30 min in ice 
cold water to terminate the reaction. The product was washed 
several times (till the pH of solution becomes neutral) using the 
centrifuge (12,000×g for 20 min) with deionized water and 
alcohol, alternatively, to remove any by-product and excess of 
hexamethylenetetramine. Finally, the purified ZnO nanorods 
were collected and dried at room temperature for 48 h. The 
resulting white precipitates were used for further 
characterization. The commercially available ZnO (bulk ZnO 
from Sigma cat # 96479) was used as the standard for 
comparison with the prepared ZnO nanorods while 
characterization. 
ZnO Nanorods Characterization 
The microscopic characterization of ZnO nanorods were 
performed using transmission electron microscopy (TEM, 
JEM-2100, JEOL Instrument, Inc., Japan) and the scanning 
electron microscopy (SEM, JEOL JSM 5610LV). Nanorods of 
zinc oxide were suspended in ethanol and exposed to ultrasonic 
waves. For TEM method, one drop of the suspension was placed 
on 300 mesh copper grip, which was coated with holey carbon 
film. Then the sample was dehydrated at 40ºC. In case of SEM, 
the obtained solution was dropped on a carbon tape. Then the 
sample was dehydrated at 50ºC. The structural characterizations 
were performed using “Rigaku D-max” X-ray diffractometer 
equipped with Cu Kα radiation (λ = 1.5417Å, 40 kV at 40 mA). 
The structural and molecular composition of nanorods was 
evaluated by Fourier transform infrared spectroscopy 
(PerkinElmer, FT-IR system spectrum GX) absorbance spectra. 
Samples were analyzed using an attenuated total reactance 
attachment from 500 cm-1 to 4000 cm-1. 
Cell Culture and Treatment 
Hela Cells (CCL-2) were purchased from American Type 
Culture Collection (Manassas, VA), cultured in DMEM with 
10% FBS, 100 IU/ml of penicillin, and 100 µg/ml of 
streptomycin and incubated in a water-saturated atmosphere 
containing 5% CO2 at 37ºC incubator. For all studies, zinc oxide 
nanorods stocks (5 mg/ml) were prepared by dissolving in 
phosphate buffer saline (PBS) pH 7. For control experiments, 
cells were treated with equivalent volume of PBS. 
Detection of Reactive Oxygen Species 
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The generation of intracellular reactive oxygen species 
(ROS) was measured using real time assay as described earlier 
[19]. Briefly, hela cells (1×105 cells/well) were seeded in a 
96-well plate and grown overnight at 37ºC in a humidified 
chamber with 5% CO2. The overnight grown cells were then 
treated with 10 µM of H2DCF-DA with HBSS and incubation at 
37ºC for 3 h. Following incubation, cells were washed with PBS 
and treated with various concentrations of ZnO nanorods. At 
different time intervals, the intensity of fluorescence was 
measured at excitation and emission wavelengths of 485/527 nm, 
respectively, and the values were expressed as fluorescence 
units. 
Cell Viability Assay 
The assay for cytotoxicity was performed using MTT, a 
tetrazole dye, as described earlier [20]. Equal numbers of hela 
cells (2000 cells/well) were seeded in a 96-well plate and grown 
overnight at 37ºC in a humidified chamber with 5% CO2. Briefly, 
following overnight growth, the cells were treated with different 
concentrations of ZnO nanorods and incubated for 72 h at 37ºC. 
Thereafter, the cells were washed with PBS and MTT was added 
to a final concentration of 125 µg/ml and incubated for another 3 
h at 37ºC. The formazans formed inside the cells were extracted 
using acidic methanol and the absorbance was measured at 570 
nm. To reconfirm the cell viability results, a live-dead cell assay 
was performed essentially as described by Manna et al [19]. 
Briefly, following treatment with 5 and 10 µg/ml of ZnO 
nanorods, approximately 105 cells were stained with Live/ Dead 
reagent (5 µM ethidium homodimer, 5 µM calcein- AM, 
Molecular Probes, Eugene, OR) and then incubated at 37ºC for 
30 min. The stained cells were analyzed under fluorescent 
microscope (Zeiss, Germany). 
Lipid Peroxidation Assay 
Lipid peroxidation assay was measured using a kit from 
Cayman Chemicals as described earlier [21]. Equal numbers of 
hela cells (4 × 105 cells/well) were seeded in a 6-well plate and 
grown overnight at 37ºC in a humidified chamber with 5% CO2. 
Following incubation, cells were washed with PBS and treated 
with 5 and 10 µg/ml of ZnO nanorods and incubated for 24 h at 
37ºC. The cells were then scraped using PBS, sonicated, 
centrifuged and followed by protein estimation using coomassie 
plus protein assay reagent. Fifty micrograms of cell lysate was 
mixed with equal volume of pre-chilled methanol-chloroform 
mixture and centrifuged at 1500×g for 10 min. The 
hydroperoxides presented in the supernatant were collected and 
used for the estimation of LPO indicator malondialdehyde 
(MDA). Finally, freshly prepared chromogen was added and 
absorbance was measured at 500 nm. 
Glutathione (GSH) Assay 
The concentration of intra cellular GSH was measured as 
described earlier [22]. In brief, equal numbers of hela cells (4 × 
105 cells/well) were seeded in a 6-well plate and grown overnight 
at 37ºC in a humidified chamber with 5% CO2. The cells were 
then treated with 5 and 10 µg/ml of ZnO nanorods and incubated 
for 24 h at 37ºC. Then, the cells were scraped and homogenized 
using PBS. Fifty micrograms of protein was deproteinized using 
5% 5-sulfosalicylic acid dihydrate solution and sodium 
carbonate (400mM) followed by 1:8 dilutions with 
phosphate-EDTA buffer and incubated for 10 minutes at room 
temperature. The supernatant was then treated with 5, 5- 
di-thiobis (2-nitrobenzoic acid; DTNB) and incubated again at 
room temperature for 10 min. The GSH activity was measured at 
415 nm absorbance. 
Total Superoxide Dismutase Assay 
Equal numbers of hela cells (4 × 105 cells/well) were seeded 
in 6-well plates and grown overnight at 37ºC in a humidified 
chamber with 5% CO2. The cells were then treated with 5 and 10 
µg/ml of ZnO nanorods and incubated for 24 h at 37ºC. Fifty 
micrograms of protein extracts were used to assay total SOD 
activities using the manufacturer’s protocol. Briefly, SOD 
reaction buffer was mixed with xanthine solution followed by 
NBT solution and then the sample proteins were added and the 
absorbance was set to zero at 550 nm. Finally, XOD solution was 
added to each sample and readings were taken at 550 nm every 
30 seconds for a period of 5 minutes. The total SOD activity was 
measured according to manufacturer’s instructions. 
Results and Discussion 
Figure 1 shows the crystalline structure of the synthesized 
ZnO nanorods measured using XRD. It can be seen that all 
diffraction peaks are caused by crystalline ZnO with the 
hexagonal wurtzite structure (space group: P63mc (186); a = 
0.3249 nm, c = 0.5206 nm). The data are in agreement with the 
Joint Committee on Powder Diffraction Standards (JCPDS) card 
for ZnO (JCPDS 036-1451). No characteristic peaks of impurity 
phases such as Zn or Zn(OH)2 were observed. Also, no 
diffraction peaks except ZnO were found. As seen in Fig. 1, the 
strongest detected (h k l) peaks are at 2θº values of 31.7º, 34.4º, 
36.2º, 47.5º and 56.6º corresponding to the following lattice 
planes: (100), (002), (101), (102), and (110) respectively. The 
XRD pattern indicates a (002)-preferred orientation, which 
suggests that the rods are quasi-aligned with the optical c-axis 
which is oriented perpendicularly to the substrate surface. 
Figure 2 (a&b) shows the SEM micrograph collected on 
synthesized ZnO nanorods surface morphology. The nanorod 
was grown perpendicular to the long-axis of the matrix rod and 
grew along the [001] direction, which is the nature of ZnO 
growth. The morphology of ZnO from the individual crystalline 
nucleus, was further confirmed by the TEM image as shown in 
Fig. 2 (c&d). A similar morphology of ZnO was previously 
observed by [23]. Though the rod cores were monodisperse, the 
 
FIG. 1. X-ray diffraction patterns of ZnO nanorods. 
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length of the nanorod was estimated to be around 21 nm in 
diameter and the length around 50 nm. 
Figure 3 illustrates the FTIR spectra of the synthesized 
ZnO nanorods with hexamethylenetetramine at room 
temperature. The characteristic absorbances were collected in 
the IR range from 4000 to 400 cm-1. A peak at 418 cm-1 is the 
stretching vibration of the Zn-O bond in ZnO particles. The 
peaks at 2857 cm-1 are assigned to the vibration of the C-H bond 
of the precursor. A broad absorption band at 3423 cm-1 in the IR 
spectra of ZnO particles can be seen, and these are attributed to 
the hydroxyl groups. Because the samples were immersed in the 
water during the growth of ZnO nanorods, the oxygen adsorbed 
to the surface would rather become O-H. 
The production of free radicals has been found in a diverse 
range of nanomaterials which is one of the primary mechanisms 
of NPs toxicity [2]. Oxidative stress is caused by an imbalance in 
the level of reactive oxygen and a biological system's ability to 
readily detoxify the reactive intermediates. Increased level of 
oxidative damage causes a net stress on the normal body 
functions, leading to a gradual loss of vital physiological 
functions. In order to check our synthesized ZnO nanorods for its 
biocompatibility, we used hela cells; an immortalized cervical 
cancer cells. Hela cells were treated with different concentration 
(0.5, 1.0, 2.0, 2.5, 5.0, 10 μg/ml) of ZnO nanorods for 3 h. They 
showed no significant induction of ROS (see Fig. 4a). Our earlier 
studies using different nanoparticles such as single and multi 
walled carbon nanotubes showed significantly increased levels 
of ROS at 5-10 µg/ml. [19-22], whereas, here in ZnO nanorods, 
we did not detect any increase in ROS level even in 20 µg/ml 
(data not shown). The time kinetics was also performed to check 
the formation of ROS (see Fig. 4b). Our data show that, there is 
no significant ROS level formed as early as 30 min with 10 
μg/ml of ZnO nanorods and remained same till 150 min. 
However, at later time intervals the increase in ROS was 
observed in 10 µg/ml but very less as compared to the control. 
This may be due to osmotic pressure created by excess of 
nanorods. Next, we investigated the level of lipid peroxidation in 
ZnO nanorods exposed hela cells; another possible player for 
oxidative stress induction. As shown in Fig. 5, we observed very 
minimal (as low as 0.1 fold) increase in lipid peroxidation level 
with 10 μg/ml of ZnO nanorods as compared to the control. 
In order to check whether ZnO nanorod has any role on 
toxicity without altering oxidative stress, we extended our 
studies by analyzing cell damage using MTT assay after 
exposing to various concentration of ZnO nanorods (0.5, 1.0, 2, 
2.5, 5.0, 10 μg/ml) (see Fig. 6a). The MTT assay showed no 
significant decrease in cell viability suggesting that ZnO 
nanorods did not have any effect on cell toxicity. We observed 
that more than 98% of cells were viable at concentration of 10 
μg/ml ZnO nanorods which is also confirmed by live dead cell 
assay (see Fig. 6b). Fifty percentage of cell death was observed 
in mouse neuroblastoma cells using 100 µg/ml of ZnO [24], 
whereas other reports have also shown 100% cytotoxicity at 15 
µg/ml of ZnO on mesothelioma MSTO-211H or rodent 3T3 
 
FIG. 2. (a&b) Scanning electron micrograph of ZnO nanorods. (c&d) 
Transmission electron micrograph of ZnO nanorods.  
 
FIG. 3. FT-IR spectra for ZnO nanorods . 
 
FIG. 4. Effect of ZnO nanorods on oxidative stress. Equal numbers of 1 × 105  hela cells/well were grown for 18 h. (a) The grown cells were incubated with 10 μM of DCF 
for 3 h, treated with different concentration of ZnO nanorods. Fluorescence was measured at excitation and emission wavelengths of 485 and 527 nm, respectively, at the 
end of 3 h. (b) Time kinetics of ROS formation by ZnO nanorods. Overnight grown hela cells were treated with 1, 5, and 10 μg/ml of ZnO nanorods. Fluorescence was 
measured at excitation and emission wavelengths of 485 and 527 nm, respectively, at different time points. The values are expressed as DCF fluorescence units, mean ± SD 
of eight wells and the figure is a representative of three experiments performed independently. 
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fibroblast cells [25], and 90% cell death with 20 mgL−1 of ZnO 
nanoparticles on HELF cells [26]. Also, 5 mM of ZnO 
nanoparticle are shown to be less toxic to human T cells [27]. 
Previous studies from our laboratory on hela cells and other cells 
such as lung epithelial, H1299, A549 and HaCaT cells showed 
the decrease in cell viability at 5 µg/ml when they were exposed 
to SWCNT and MWCNT [19-22]. 
        During normal conditions, important antioxidant enzymes 
Glutathione (GSH), along with superoxide dismutase SOD are 
effective in scavenging free radicals [20]. Therefore in this study, 
the effect of ZnO nanorods on levels of antioxidants, GSH and 
SOD assays were performed. GSH is a ubiquitous sulfhydryl 
containing molecule in cells that is responsible for maintaining 
cellular oxidation-reduction homeostasis [28]. Hela cells treated 
with 5 and 10 μg/ml of ZnO nanorods for 24 h were used to 
analyze GSH and SOD levels (see Fig. 7 a&b) and showed no 
significant decreasing level of total GSH and SOD levels even at 
high concentration of 10 μg/ml. 
Conclusion 
In this study, we have synthesized ZnO nanorods by mixing 
zinc acetate and hexamethylenetetramine and characterized 
using X-ray diffraction, scanning electron microscopy, high 
resolution transmission electron microscopy, and fourier 
transform infrared spectroscopy. XRD measurements indicate 
that the synthesized nanorods are in the hexagonal wurtzite 
structure with high crystallinity and preferred growth direction 
of the c-axis. The length of the nanorods estimated by TEM and 
XRD is around 21 nm in diameter and 50 nm in length. FT-IR 
characterization confirmed the presence of nanorods. In addition, 
our toxicological studies using synthesized ZnO nanorods on 
hela cells showed no significant induction of oxidative stress and 
cell death even at high concentration of 10 μg/ml. In summary, 
we report here the successful preparation of ZnO nanorods, 
characterization and toxicological studies on hela cells and 
conclude that ZnO nanorods could be the safe nanomaterial for 
biological applications. 
This work was supported by NASA funding NNX08BA47A, 
NCC-1-02038, NIH-1P20MD001822-1, NSF (RISE) 
HRD-0734846. 
Received 3 March 2010; accepted 16 March 2010; published 
online 23 March 2010.  
 
FIG. 6. Effect of ZnO nanorods on cell viability. HeLa cells (2000/well in a 
96-well plate) were incubated for 12 h and treated with different concentration of 
ZnO nanorods for 72 h. (a) Cell viability was assayed by MTT dye uptake. The 
mean absorbance at 570 nm is represented as cell viability percentage of the 
control and is mean ± SD of eight wells. (b) HeLa cells were treated with 5 µg/ ml
and10 µg/ml of ZnO nanorods for 72 h and the dead cell (red color) numbers were 
counted. The percentage of dead cells is indicated below each photograph. 
 
FIG. 5. Effect of ZnO nanorods on lipid peroxidation: 4x105 hela cells were 
grown for 24 h. Cells were then treated with 5 and 10 μg/ml of ZnO nanorods and 
allowed to grow for 24 h at 37ºC. Lipid peroxidation levels were measured from 
chloroform-methanol extracts. Values are mean ± SD of three independent 
experiments. 
 
FIG. 7. Effect of ZnO nanorods on antioxidants level. Equal numbers of 4 × 105  hela cells/well were grown for 24 h and treated with 5 and 10 μg/mL of ZnO nanorods and 
allowed to grow for additional 24 h. a) Total GSH was measured at 412 nm and the values were expressed in nanomoles. b) Superoxide dismutase activity was assayed from 
each sample and activity was measured at 550 nm. Values are mean ± SD of three experiments performed independently. 
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